title: Enhanced bioavailability of cyclosporine using a new oral formulation (Sandimmun optoral) in a liver-grafted patient with severe cholestasis.
authors.forename: M
authors.initials: M
authors.lastname: Winkler
authors.forename: B
authors.initials: B
authors.lastname: Ringe
authors.forename: K
authors.initials: K
authors.lastname: Schneider
authors.forename: A
authors.initials: A
authors.lastname: Maibücher
authors.forename: L
authors.initials: L
authors.lastname: Färber
authors.forename: H
authors.initials: H
authors.lastname: Wietholtz
authors.forename: M
authors.initials: M
authors.lastname: Manns
authors.forename: R
authors.initials: R
authors.lastname: Pichlmayr
mesh_terms: D000284:Administration, Oral; D001682:Biological Availability; D002779:Cholestasis / Q000150:complications* / Q000378:metabolism; D016572:Cyclosporine / Q000493:pharmacokinetics*; D004655:Emulsions; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007408:Intestinal Absorption; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged
chemical_list: D004655:Emulsions; D016572:Cyclosporine